FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023593605> ?p ?o ?g. }

• W2023593605 endingPage "1164" @default.
• W2023593605 startingPage "1155" @default.
• W2023593605 abstract "A phase I trial was conducted to evaluate the safety, tumour and normal tissue localization, pharmacokinetics and radiation dosimetry of Tc-hR3, a humanized monoclonal antibody directed towards the epidermal growth factor receptor, in 12 patients with recurrent or metastatic epithelial malignancies. Patients were injected intravenously with 3.0 mg or 6.0 mg (1010 MBq) of Tc-hR3. Blood and plasma concentrations of radioactivity were measured and a complete 24 h urine collection was obtained. Whole-body images were acquired up to 24 h post-injection and normal organ uptake quantified. Radiation dosimetry was estimated using MIRDose. Safety was evaluated by clinical observation, biochemical/haematological testing and by measuring immune response to Tc-hR3. There were no adverse effects, no changes in biochemical/haematological indices and no immune response to Tc-hR3. Tc-hR3 was rapidly cleared from the blood with a distribution half-life of 10.8+/-3.8 min. The volume of distribution, and clearance, were 180+/-37 ml.kg and 14+/-3 ml.kg.min, respectively. The elimination phase could not be discerned due to increasing blood radioactivity at later times. About 19-24% was excreted in the urine. Normal tissue uptake was mainly in the liver (44-50%), spleen (3-4%) and kidneys (3%). Imaging was positive in one patient with squamous cell carcinoma of the mouth and an involved cervical lymph node. The whole-body radiation dose from Tc-hR3 was 1.34+/-0.02x10 mSv.Bq. We conclude that Tc-hR3 exhibited an excellent safety profile. Future studies to determine the sensitivity and specificity of imaging with Tc-hR3 in a larger group of patients with pre-selection for epidermal growth factor receptor positivity are planned." @default.
• W2023593605 created "2016-06-24" @default.
• W2023593605 creator A5003197899 @default.
• W2023593605 creator A5018001559 @default.
• W2023593605 creator A5023465589 @default.
• W2023593605 creator A5033362815 @default.
• W2023593605 creator A5053714304 @default.
• W2023593605 creator A5056633890 @default.
• W2023593605 creator A5069407378 @default.
• W2023593605 creator A5070294345 @default.
• W2023593605 creator A5074404084 @default.
• W2023593605 creator A5079845216 @default.
• W2023593605 date "2002-12-01" @default.
• W2023593605 modified "2023-10-14" @default.
• W2023593605 title "A phase I study of 99mTc-hR3 (DiaCIM®), a humanized immunoconjugate directed towards the epidermal growth factor receptor" @default.
• W2023593605 cites W1904016327 @default.
• W2023593605 cites W1939364580 @default.
• W2023593605 cites W1986807124 @default.
• W2023593605 cites W1998113566 @default.
• W2023593605 cites W2001229261 @default.
• W2023593605 cites W2008249862 @default.
• W2023593605 cites W2016453061 @default.
• W2023593605 cites W2021007834 @default.
• W2023593605 cites W2032575695 @default.
• W2023593605 cites W2035563619 @default.
• W2023593605 cites W2064453375 @default.
• W2023593605 cites W2066348329 @default.
• W2023593605 cites W2073256585 @default.
• W2023593605 cites W2091530883 @default.
• W2023593605 cites W2110439220 @default.
• W2023593605 cites W2173906117 @default.
• W2023593605 cites W2339422318 @default.
• W2023593605 doi "https://doi.org/10.1097/00006231-200212000-00002" @default.
• W2023593605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12464779" @default.
• W2023593605 hasPublicationYear "2002" @default.
• W2023593605 type Work @default.
• W2023593605 sameAs 2023593605 @default.
• W2023593605 citedByCount "31" @default.
• W2023593605 countsByYear W20235936052012 @default.
• W2023593605 countsByYear W20235936052013 @default.
• W2023593605 countsByYear W20235936052014 @default.
• W2023593605 countsByYear W20235936052016 @default.
• W2023593605 countsByYear W20235936052018 @default.
• W2023593605 countsByYear W20235936052021 @default.
• W2023593605 crossrefType "journal-article" @default.
• W2023593605 hasAuthorship W2023593605A5003197899 @default.
• W2023593605 hasAuthorship W2023593605A5018001559 @default.
• W2023593605 hasAuthorship W2023593605A5023465589 @default.
• W2023593605 hasAuthorship W2023593605A5033362815 @default.
• W2023593605 hasAuthorship W2023593605A5053714304 @default.
• W2023593605 hasAuthorship W2023593605A5056633890 @default.
• W2023593605 hasAuthorship W2023593605A5069407378 @default.
• W2023593605 hasAuthorship W2023593605A5070294345 @default.
• W2023593605 hasAuthorship W2023593605A5074404084 @default.
• W2023593605 hasAuthorship W2023593605A5079845216 @default.
• W2023593605 hasConcept C112705442 @default.
• W2023593605 hasConcept C126322002 @default.
• W2023593605 hasConcept C126894567 @default.
• W2023593605 hasConcept C139254425 @default.
• W2023593605 hasConcept C185592680 @default.
• W2023593605 hasConcept C202751555 @default.
• W2023593605 hasConcept C2777807558 @default.
• W2023593605 hasConcept C2780026642 @default.
• W2023593605 hasConcept C2989005 @default.
• W2023593605 hasConcept C55493867 @default.
• W2023593605 hasConcept C71924100 @default.
• W2023593605 hasConcept C75088862 @default.
• W2023593605 hasConceptScore W2023593605C112705442 @default.
• W2023593605 hasConceptScore W2023593605C126322002 @default.
• W2023593605 hasConceptScore W2023593605C126894567 @default.
• W2023593605 hasConceptScore W2023593605C139254425 @default.
• W2023593605 hasConceptScore W2023593605C185592680 @default.
• W2023593605 hasConceptScore W2023593605C202751555 @default.
• W2023593605 hasConceptScore W2023593605C2777807558 @default.
• W2023593605 hasConceptScore W2023593605C2780026642 @default.
• W2023593605 hasConceptScore W2023593605C2989005 @default.
• W2023593605 hasConceptScore W2023593605C55493867 @default.
• W2023593605 hasConceptScore W2023593605C71924100 @default.
• W2023593605 hasConceptScore W2023593605C75088862 @default.
• W2023593605 hasIssue "12" @default.
• W2023593605 hasLocation W20235936051 @default.
• W2023593605 hasLocation W20235936052 @default.
• W2023593605 hasOpenAccess W2023593605 @default.
• W2023593605 hasPrimaryLocation W20235936051 @default.
• W2023593605 hasRelatedWork W1987262526 @default.
• W2023593605 hasRelatedWork W2074647699 @default.
• W2023593605 hasRelatedWork W2077458212 @default.
• W2023593605 hasRelatedWork W2169566797 @default.
• W2023593605 hasRelatedWork W2387755006 @default.
• W2023593605 hasRelatedWork W2518660099 @default.
• W2023593605 hasRelatedWork W2772744872 @default.
• W2023593605 hasRelatedWork W2807632826 @default.
• W2023593605 hasRelatedWork W2885376240 @default.
• W2023593605 hasRelatedWork W2995817629 @default.
• W2023593605 hasVolume "23" @default.
• W2023593605 isParatext "false" @default.
• W2023593605 isRetracted "false" @default.
• W2023593605 magId "2023593605" @default.

• next